Bortezomib in Anti-Cancer Activity: A Potential Drug
<p>26S proteasome is an intracellular; ATP dependent enzymatic complex degrades ubiquitin-tagged proteins and maintains cellular homeostasis. The orderly degraded proteins including cyclins, caspases, Bcl-xL, p53, cell adhesion molecules are involved in cell-cycle progression, tumor suppressio...
Saved in:
Main Authors: | Rajagopal Appavu (Author), Deepa Mohan (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Cancer Therapy - Peertechz Publications,
2016-03-08.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-cancer Drugs Nature, Synthesis and Cell
Published: (2016) -
Unique Aspects of Anti-cancer Drug Development
Published: (2017) -
Matricellular Receptors as Potential Targets in Anti-Cancer Therapeutic Strategies
by: Herve Emonard
Published: (2016) -
Disease biology alters the response to frontline bortezomib, lenalidomide and dexamethasone in Multiple Myeloma
by: Amany R Keruakous, et al.
Published: (2021) -
Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression
Published: (2022)